ReviewVaccines2025
Peste Des Petits Ruminants in Pakistan: Current Status, Challenges and Prospects for Vaccine Development.
Review in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peste des petits ruminants (PPR) is a highly contagious viral disease that affects goats and sheep, causing severe clinical signs, high mortality, and significant economic losses in many developing countries. Pakistan is one of the endemic regions where PPR outbreaks caused by the Asian lineage IV virus have been reported frequently, affecting the livelihoods of millions of smallholder farmers who depend on these animals for food security and income generation. In this review, we provide a comprehensive overview of the current status, challenges and prospects for vaccine development against PPR in Pakistan. We discuss the epidemiology, diagnosis, and control of PPR in Pakistan, as well as the existing vaccines based on the attenuated strains and their limitations, such as low thermostability, short shelf life, and inability to differentiate between infected and vaccinated animals. We also highlight the recent advances in vaccine research and development, such as recombinant and vectored vaccines, thermostable formulations, and novel delivery methods that could overcome these limitations and enhance the immunogenicity and safety of PPR vaccines. We review the current and potential strategies for vaccine deployment, such as mass vaccination, targeted vaccination, ring vaccination, and their implications for the global eradication of PPR by 2030. We conclude by providing some recommendations for future research and development to improve vaccine efficacy, safety, and coverage in Pakistan, as well as to monitor the impact of vaccination on PPR incidence and prevalence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.